Saturday, July 11, 2026

Drug profile · INN

flutemetamol (18f)

flutemetamol (18f) (VIZAMYL) is a diagnostic agent.

EMA: approved Various (V09) V09AX04
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — flutemetamol (18f)
Class
Various (V09)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

flutemetamol (18f) (VIZAMYL) is a diagnostic agent.

Key facts

INN flutemetamol (18f)
Brand VIZAMYL
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09AX04

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. BP44745 Phase 2 · HOFFMANN-LA ROCHE · Alzheimer’s Disease
  2. IIBSP-HEA-2022-145 Phase 2 · George Institute for · cognitive impairment
  3. VIZAMYL 400 MBq/mL solution for injection Phase 2 · Telethon Foundation · cardiac amyloidosis

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is flutemetamol (18f)?

flutemetamol (18f) (VIZAMYL) is a diagnostic agent.

What is the brand name for flutemetamol (18f)?

VIZAMYL is a marketed brand name for flutemetamol (18f). Check FDA Drugs@FDA for the current US label holder and prescribing information.